Study finds no significant differences between commonly used carotid stenting systems in US

January 17, 2014 by Jessica Mikulski

(Medical Xpress)—A study conducted by researchers from several institutions, including the Perelman School of Medicine at the University of Pennsylvania, has found similarly low rates of complication and death among U.S. patients who are treated with the three most common systems for placing stents in blocked carotid arteries of the neck.

The study, published online this week by JACC: Cardiovascular Interventions, is the first true comparative effectiveness analysis of stenting platforms. Extensive similar work has been performed with coronary stents but no one has previously attempted to clarify these issues in carotid artery disease.

"We found low rates of in-hospital death and stroke with carotid stenting regardless of the devices used: on the order of two percent," said lead author Jay Giri, MD, MPH, assistant professor of Clinical Medicine at Penn. "A tremendous amount of time and energy has been spent theorizing about various technical considerations of carotid stenting systems that might make one superior to another. Our study effectively argues that continued focus on these specific technical aspects is unlikely to significantly improve stroke and death rates around carotid stenting. The bottom line is that our finding should provide support for operators to use their judgment to select the stent most favorable for a particular anatomic or clinical situation."

The study analyzed 12,135 consecutive carotid stent procedures in the National Cardiovascular Data Registry performed between January, 2007 and March, 2012. The Penn researchers compared rates of in-hospital combined death/stroke among patients treated with the three most commonly used carotid stenting systems in this country. (An embolic protection device is a small filter that helps prevent strokes by catching the clots or debris that may break away from the plaque during the procedure.) Until this study, little was known about current usage patterns and differences in outcomes with these devices.

During carotid artery stenting an interventional cardiologist or vascular surgeon inserts a slender, metal-mesh tube, called a stent, which expands inside a patient's to increase blood flow in areas blocked by plaque.

Hardening of the arteries, also known as atherosclerosis, can cause a build-up of plaque. This can occur as a result of the aging process and dietary and exercise patterns. As plaque accumulates, arteries can narrow and stiffen. Eventually, enough plaque may build up to reduce blood flow through the arteries, or cause blood clots or pieces of plaque to break free and block the arteries in the brain beyond the plaque. This may result in stroke or death if untreated.

The study also found that in nearly 80 percent of the cases examined, physicians paired stents with the corresponding embolic protection device produced by the stent manufacturer. "We wanted to find out whether physicians were mixing and matching stents and embolic protection devices from different companies during carotid stenting.. In other types of non-carotid stenting, doctors often mix and match products from different companies." said Giri. "With carotids, by and large, they don't. They use companion stents and embolic protection devices from one company."

There are several factors that may influence this pattern of use. First, the FDA approves systems as a unit of stent and embolic protection device. Operators may be more comfortable using an FDA-approved unit rather than "mixing and matching" with other embolic protection devices. Additionally, reimbursement restrictions from CMS likely have a large impact on this usage pattern.

Explore further: Stenting of neck arteries tied to higher stroke risk in seniors

More information: Giri J, Kennedy KF, Weinberg I, et al. "Comparative Effectiveness of Commonly Used Devices for Carotid Artery Stenting: An NCDR (National Cardiovascular Data Registry) Analysis." J Am Coll Cardiol Intv. 2014. DOI: 10.1016/j.jcin.2013.10.014.

Related Stories

Stenting of neck arteries tied to higher stroke risk in seniors

October 24, 2013
(HealthDay)—For patients being treated for a blockage in the artery that supplies blood to the head, inserting a stent may raise the risk of stroke more in elderly patients than in younger patients, a large new evidence ...

Stenting for stroke prevention becoming safer in high-risk patients

January 11, 2012
Placing a stent in a key artery in the neck is safer than ever in patients ineligible for the standard surgical treatment of carotid artery disease, according to a new study published online today in the Journal of Vascular ...

Procedure to open blocked carotid arteries tested

September 27, 2013
(Medical Xpress)—Doctors at Washington University School of Medicine in St. Louis are investigating a minimally invasive procedure to open blocked carotid arteries in patients whose poor health or advanced age makes the ...

Skip the balloon after placing carotid stent, surgeons suggest

December 11, 2013
Johns Hopkins surgeons say skipping one commonly taken step during a routine procedure to insert a wire mesh stent into a partially blocked carotid artery appears to prevent patients from developing dangerously low blood ...

Cleveland Clinic study finds lowest risk treatment for severe carotid and coronary disease

July 31, 2013
Of the three most common treatment approaches for patients with severe carotid and coronary artery disease, patients who underwent stenting of the carotid artery followed by open heart surgery had the best outcomes, according ...

Researchers study outcomes of carotid artery stenting following prior carotid procedure

November 14, 2011
A new study shows that carotid artery stenting (CAS) following prior same-side carotid artery revascularization is safe, effective and results in lower incidences of in-hospital death, stroke and heart attack compared to ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.